New research suggests that paranoia and excessive teleological thinking—two forms of distorted beliefs about intention—are ...

Schizophrenia is a serious mental disorder that affects around 1% of the world's population. Researchers have identified a deficit in contrast perception in people with schizophrenia. According to a ...

People with schizophrenia experience impaired contrast perception, affecting their ability to differentiate light intensity ...

As per the Brain and Behavior Research Foundation, it combines two compounds called xanomeline and trospium chloride. This is ...

People with schizophrenia have at least two of these symptoms for at least six months. One of them must be hallucinations, delusions, or disorganized speech. For example, hearing a voice that ...

Boehringer Ingelheim’s investigational schizophrenia candidate has failed to improve cognitive impairment or functioning in a trio of late-stage trials. The phase 3 program missed both primary ...

Boehringer Ingelheim today announced top-line results from the Phase III CONNEX clinical program in cognitive impairment in adults with schizophrenia, showing primary and key secondary endpoints ...

Background: Visual hallucinations occur in various neurological diseases, but are most prominent in Lewy body dementia, Parkinson's disease and schizophrenia. The lifetime prevalence of visual ...

In this article, we review the use of AChEI's for the targeted treatment of visual hallucinations in schizophrenia.

Out of 100,000 people, approximately 15-100 may have psychosis, and 2-7 may have schizophrenia. Psychotic symptoms include delusions, hallucinations, incoherent speech (unclear or nonsensical ...